Item 5.02. Departure of Directors or Certain Officers; Election of Directors;


           Appointment of Certain Officers; Compensatory Arrangements of Certain
           Officers.

Appointment of Inderpal S. Bhandari to the Board of Directors

On September 6, 2022, the Board of Directors (the "Board") of Walgreens Boots Alliance, Inc. (the "Company"), upon the recommendation of the Nominating and Governance Committee, appointed Inderpal S. Bhandari to the Board effective immediately for a term continuing through the Company's next Annual Meeting of Stockholders, when Mr. Bhandari is expected to be a nominee for election by stockholders. The Board also appointed Mr. Bhandari to serve on the Finance and Technology Committee of the Board.

Mr. Bhandari, age 62, has served as the Global Chief Data Officer of International Business Machines Corporation ("IBM") since December 2015. From 2014 to 2015, Mr. Bhandari served as Senior Vice President and Chief Data Officer of Cambia Health Solutions ("Cambia"), where he led the development of Cambia's data strategy and drove the transformation of consumer experience strategies. He was previously the Chief Data Officer and Vice President, Knowledge Solutions of Express Scripts Inc. and the Chief Data Officer and Vice President, Health Data & Analytics of Medco Health Solutions, Inc.

There were no arrangements or understandings pursuant to which Mr. Bhandari was appointed to the Board, and since the beginning of the last fiscal year, there have been no related party transactions between the Company and Mr. Bhandari that would be reportable under Item 404(a) of Regulation S-K. Mr. Bhandari's compensation for service as a non-employee director will be consistent with that of the Company's other non-employee directors, subject to proration to reflect the commencement date of his service on the Board. The non-employee director compensation program is described under the caption "Director Compensation" in the Company's definitive proxy statement for its January 27, 2022 Annual Meeting of Stockholders filed with the Securities and Exchange Commission on December 8, 2021.




Item 8.01 Other Events.

On September 8, 2022, the Company issued a press release announcing the appointment of Mr. Bhandari to the Board. A copy of the press release is attached as Exhibit 99.1 hereto and incorporated in this Item 8.01 by reference.

Item 9.01 Financial Statements and Exhibits.




(d) Exhibits

Exhibit
  No.       Description

99.1          Press Release issued September 8, 2022

104         Cover Page Interactive Data File (embedded within the Inline XBRL document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses